OCGN
Ocugen, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.06
+2.91%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 64.63x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -21.71x
- Price / sales
- 78.48x
- Price / cash flow
- -5.87x
Enterprise value
- Enterprise value
- $347.4M
- EV / sales
- 75.85x
- EV / EBITDA
- -4.95x
- EV / EBIT
- -5.04x
- Market cap
- $359.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026